These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4038446)

  • 1. [Effect of cis-platinum in neuroblastoma].
    Nakadate H; Nishi M; Hattori T; Hatae Y; Takeda T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):147-50. PubMed ID: 4038446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of cis-DDP in children with refractory malignant tumors].
    Nakadate H; Kobayashi R; Nishi M; Hatae Y; Takeda T; Uchino J; Hirama T; Kobayashi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):598-603. PubMed ID: 3954383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of two administration schedules of cis-dichlorodiammineplatinum (DDP) in ovarian and head and neck cancers: a CMEA chemotherapy group study.
    Mechl Z; Kerpel-Fronius S; Decker A; Gorbunova VA; Gürtler R; Hindy I; Krafft W; Kolarić K; Nekulova M; Sopkova B
    Neoplasma; 1987; 34(1):37-43. PubMed ID: 3561604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cis-diamminedichloroplatinum(II) chemotherapy in advanced pancreatic carcinoma].
    Tajiri H; Yoshimori M; Hijikata A; Nakamura K; Ohkura H; Okazaki N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3101-4. PubMed ID: 3674895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
    Canpolat C; Pearson P; Robertson R; Jaffe N
    Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
    ; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
    J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
    Egorin MJ; Van Echo DA; Tipping SJ; Olman EA; Whitacre MY; Thompson BW; Aisner J
    Cancer Res; 1984 Nov; 44(11):5432-8. PubMed ID: 6386150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of prolonged intravenous infusions of cisplatin in patients with malignant neoplasms].
    Tiuliadin SA
    Vopr Onkol; 1983; 29(12):40-4. PubMed ID: 6582683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.
    Ostrow S; Egorin M; Aisner J; Bachur N; Wiernik PH
    Cancer Clin Trials; 1980; 3(1):23-7. PubMed ID: 7190082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with cisplatin (Platidiam) chemotherapy in secondary resistant ovarian carcinomas].
    Krafft W; Mechl Z; Behling H; Brückmann D; Preibsch W; Kademann J; Schirmer A
    Zentralbl Gynakol; 1984; 106(3):175-83. PubMed ID: 6538371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
    Matthay KK; Tan JC; Villablanca JG; Yanik GA; Veatch J; Franc B; Twomey E; Horn B; Reynolds CP; Groshen S; Seeger RC; Maris JM
    J Clin Oncol; 2006 Jan; 24(3):500-6. PubMed ID: 16421427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.